Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 15 Oct 2026
- Closes
- 17 Nov 2026, 23:59 UTC
- Reference
- RFA-DK-27-122
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)”. Submissions close on 17 November 2026, 32 days from today. Quote reference RFA-DK-27-122 in any correspondence with the buyer. FreeTender has recorded 440 notices from this buyer since 2023, 379 of them currently open. There are 368 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Details
The purpose of this NOFO is to continue the Physiology of the Weight Reduced State (POWERS) clinical trial. The goal of POWERS is to understand the physiological processes underlying individual variability in weight regain following weight loss due to a lifestyle intervention. The continuation of POWERS will allow for the completion of the ongoing clinical trial and to conduct analysis of collected data and biospecimens.This NOFO invites a single source application from the Data Coordinating Center for the POWERS consortium. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application will be peer-reviewed, and only meritorious application(s) will be considered for funding. Eligibility: NIDDK requests a Single Source competition for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study at the University of Pittsburgh.
Expected number of awards: 1
CFDA number(s): 93.847
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 440 notices from National Institutes of Health, going back to May 2023 — 379 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 368 open Healthcare & Pharma tenders in United States. This one closes in 32 days.
More from this buyer
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)· closes 11 Feb
- Specialized Alcohol Research Centers (P50 Clinical trial Optional)· closes 27 Jan
- Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)· closes 16 Nov
- Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)· closes 5 Nov
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)· closes 25 Sept
Similar Healthcare & Pharma tenders
- Apply Now: OJJDP Family Treatment Court Program (United States)· closes 16 Nov
- Boxelder JCC Medical Services — General Health Care Services· closes 5 Nov
- Powered Chiropractic Tables Salt Lake City VA Health Care System, UT· closes 30 Oct
- Perfusionist Services| NFSG — Thoracic Services· closes 6 Nov
- OH Medical Exams Blanket Purchase Agreement (BPA)· closes 27 Oct
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Конкурс по государственным закупкам медикаментов и прочих средств медицинского назначения для нужд Пограничной службы КНБ РК (способом конкурса до 8000 МРП)Республиканское государственное учреждение "Пограничная служба Комитета национальной безопасности Республики Казахстан" · Kazakhstan
- Закуп электромагнитного стимулятораНекомерческое акционерное общество "Национальный центр детской реабилитации" · Kazakhstan
- приобретение услуг по поверке медицинского оборудованиеРГУ "Департамент Пограничной службы Комитета национальной безопасности Республики Казахстан по Актюбинской области" · Kazakhstan
- медикаменты и изделия медицинского назначенияРеспубликанское государственное учреждение "Департамент Комитета национальной безопасности Республики Казахстан по Западно-Казахстанской области" · Kazakhstan
- Горно-обогатительный реагент «Золотая Цикада»/ ООО АС «Сининда-1»Акционерное общество "ЗОЛОТО СЕЛИГДАРА" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →